Stoke Therapeutics, Inc. (STOK)

SEC filing

Stoke Therapeutics, Inc.

STOK · CIK 1623526

4 · Oct 2, 2026 · GENERAL COUNSEL & CORP SEC Allan Jonathan sold 627 shares at $26.33/share ($16,509)

GENERAL COUNSEL & CORP SEC Allan Jonathan sold 627 shares at $26.33/share ($16,509)

xslF345X06/form4-10022026_091025.xml

xslF345X06/form4-10022026_091025.xmlSEC.gov

Graphics and non-inline formats (not embedded below).